General Updates

8th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir/ Madam, Sub.: Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders Ref.: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ==================================================================== This is further to our earlier intimations dated 6th July, 2026 and 7th July, 2026 in connection with Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company” or “JB Chemicals”) with Torrent Pharmaceuticals Limited (“Company” or “Transferee Company” or “Torrent Pharma”) and their respective shareholders (“Scheme”), as approved and sanctioned by the Hon’ble National Company Law Tribunal, Ahmedabad Bench (“NCLT”) vide its order dated 6th July, 2026 (“Order”). The certified copy of the order was received on 7th July, 2026. We wish to inform that Torrent Pharma and JB Chemicals have today, i.e. 8th July, 2026, filed the certified copies of the Order and the Scheme with the Registrar of Companies, Ahmedabad, Ministry of Corporate Affairs, Government of India. Accordingly, the Scheme has become effective today i.e., 8th July, 2026 (“Effective Date”) and consequently JB Chemicals stands amalgamated into and with Torrent Pharma and dissolved without being wound up. In accordance with the Scheme the Appointed Date is 21st January, 2026. Further pursuant to effectiveness of the Scheme, capital clause of the Memorandum of Association of Torrent Pharma stands amended to the extent given below: The capital of the Company is ₹ 2,55,30,00,000 /- (Rupees Two Hundred Fifty Five Crores Thirty Lakhs) divided into 46,06,00,000 (Forty Six Crores Six Lakhs) Equity Shares of ₹ 5/- (Rupees Five) each and 25,00,000 (Twenty Five Lacs) Preference Shares of ₹ 100/- (Rupees Hundred) each Email – investorservices@torrentpharma.com with power to increase and reduce the capital of the Company and to divide the shares into several classes and to attach thereto respectively such rights, privileges or conditions as may be determined by or in accordance with the Articles of Association of the Company and to vary, modify or abrogate any such rights, privileges or conditions in such manner as may be provided by the Articles of Association of the Company. Kindly take note of the above. Thanking you, Yours sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Email – investorservices@torrentpharma.com